Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis
- PMID: 16850140
- DOI: 10.1007/s00270-005-0090-4
Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis
Abstract
Purpose: To determine the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with liver cirrhosis complicated by thrombosed portal vein.
Methods: This study reviewed 15 cases of TIPS creation in 15 cirrhotic patients with portal vein thrombosis at our institution over an 8-year period. There were 2 women and 13 men with a mean age of 53 years. Indications were refractory ascites, variceal hemorrhage, and refractory pleural effusion. Clinical follow-up was performed in all patients.
Results: The technical success rate was 75% (3/4) in patients with chronic portal vein thrombosis associated with cavernomatous transformation and 91% (10/11) in patients with acute thrombosis or partial thrombosis, giving an overall success rate of 87%. Complications included postprocedural encephalopathy and localized hematoma at the access site. In patients with successful shunt placement, the total follow-up time was 223 months. The 30-day mortality rate was 13%. Two patients underwent liver transplantation at 35 days and 7 months, respectively, after TIPS insertion. One patient had an occluded shunt at 4 months with an unsuccessful revision. The remaining patients had functioning shunts at follow-up.
Conclusion: TIPS creation in thrombosed portal vein is possible and might be a treatment option in certain patients.
Comment in
-
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosis.Cardiovasc Intervent Radiol. 2007 May-Jun;30(3):545; author reply 546. doi: 10.1007/s00270-006-0321-3. Cardiovasc Intervent Radiol. 2007. PMID: 17242876 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
